Education
About Us
Working with TipRanks
Follow Us
Bluebird bio Inc (BLUE)
NASDAQ:BLUE
Total Valuation
Bluebird Bio has a market cap or net worth of $48.67M. The enterprise value is $85.38M.
Market Cap$48.67M
Enterprise Value$85.38M
Share Statistics
Bluebird Bio has 55,331,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding55,331,000
Owned by Insiders9.50%
Owned by Institutions13.80%
Financial Efficiency
Bluebird Bio’s return on equity (ROE) is 7.63 and return on invested capital (ROIC) is -82.57%.
Return on Equity (ROE)7.63
Return on Assets (ROA)-0.52
Return on Invested Capital (ROIC)-82.57%
Return on Capital Employed (ROCE)-1.95
Revenue Per Employee337.93K
Profits Per Employee-970.63K
Employee Count248
Asset Turnover0.18
Inventory Turnover1.37
Valuation Ratios
The current PE Ratio of Bluebird Bio is -0.34. Bluebird Bio’s PEG ratio is <0.01.
PE Ratio-0.34
PS Ratio0.00
PB Ratio-0.84
Price to Fair Value-2.56
Price to FCF-0.21
Price to Operating Cash Flow-0.21
PEG Ratio<0.01
Income Statement
In the last 12 months, Bluebird Bio had revenue of 83.81M and earned -240.72M in profits. Earnings per share was -24.84.
Revenue83.81M
Gross Profit-5.57M
Operating Income-270.46M
Pretax Income-240.65M
Net Income-240.72M
EBITDA-156.82M
Earnings Per Share (EPS)-24.84
Cash Flow
In the last 12 months, operating cash flow was -228.79M and capital expenditures -1.68M, giving a free cash flow of -230.47M billion.
Operating Cash Flow-228.79M
Free Cash Flow-230.47M
Free Cash Flow per Share-4.17
Dividends & Yields
Bluebird Bio pays an annual dividend of $177.66, resulting in a dividend yield of ―
Dividend Per Share$177.66
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.01
52-Week Price Change-75.15%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Bluebird Bio upcoming earnings date is Aug 12, 2025, Before Open (Confirmed).
Last Earnings DateMay 7, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend DateNov 05, 2021
Financial Position
Bluebird Bio as a current ratio of 0.48, with Debt / Equity ratio of -199.53%
Current Ratio0.48
Quick Ratio0.28
Debt to Market Cap0.88
Net Debt to EBITDA-1.89
Interest Coverage Ratio-11.98
Taxes
In the past 12 months, Bluebird Bio has paid 70.00K in taxes.
Income Tax70.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Bluebird Bio EV to EBITDA ratio is -2.40, with an EV/FCF ratio of -1.43.
EV to Sales4.50
EV to EBITDA-2.40
EV to Free Cash Flow-1.43
EV to Operating Cash Flow-1.45
Balance Sheet
Bluebird Bio has $78.74M in cash and marketable securities with $115.46M in debt, giving a net cash position of $36.71M billion.
Cash & Marketable Securities$78.74M
Total Debt$115.46M
Net Cash$36.71M
Net Cash Per Share$0.66
Tangible Book Value Per Share-$4.82
Margins
Gross margin is 27.12%, with operating margin of -322.72%, and net profit margin of -287.23%.
Gross Margin27.12%
Operating Margin-322.72%
Pretax Margin-287.14%
Net Profit Margin-287.23%
EBITDA Margin-187.12%
EBIT Margin-260.20%
Analyst Forecast
The average price target for Bluebird Bio is $8.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$8.00
Price Target Upside60.97% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast127.51%
EPS Growth Forecast56.94%